The estimated Net Worth of Todd Kevin Abraham is at least $550 ezer dollars as of 11 May 2021. Dr Abraham owns over 12,977 units of Cronos Inc stock worth over $60,990 and over the last 4 years he sold CRON stock worth over $0. In addition, he makes $488,692 as Chief Innovation Officer at Cronos Inc.
Dr has made over 2 trades of the Cronos Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 12,977 units of CRON stock worth $28,290 on 11 May 2021.
The largest trade he's ever made was buying 15,000 units of Cronos Inc stock on 7 August 2020 worth over $86,700. On average, Dr trades about 6,994 units every 69 days since 2020. As of 11 May 2021 he still owns at least 27,977 units of Cronos Inc stock.
You can see the complete history of Dr Abraham stock trades at the bottom of the page.
Dr. Todd K. Abraham is the Chief Innovation Officer at Cronos Inc.
As the Chief Innovation Officer of Cronos Inc, the total compensation of Dr Abraham at Cronos Inc is $488,692. There are 1 executives at Cronos Inc getting paid more, with Anna Shlimak having the highest compensation of $623,304.
Dr Abraham is 65, he's been the Chief Innovation Officer of Cronos Inc since . There are no older and 11 younger executives at Cronos Inc.
Todd's mailing address filed with the SEC is 111 PETER STREET, SUITE 300, , TORONTO, A6, M5V 2H1.
Over the last 4 years, insiders at Cronos Inc have traded over $30,495,757 worth of Cronos Inc stock and bought 1,848,320 units worth $4,899,192 . The most active insiders traders include Michael Ryan Gorenstein, Jason Marc Adler és Jeffrey David Jacobson. On average, Cronos Inc executives and independent directors trade stock every 15 days with the average trade being worth of $528,456. The most recent stock trade was executed by James Andrew Iii Mc Ginness on 29 August 2024, trading 14,618 units of CRON stock currently worth $31,867.
cronos group is a globally diversified and vertically integrated cannabis company with a presence across four continents. the company operates two wholly-owned canadian licensed producers regulated under health canada’s access to cannabis for medical purposes regulations: peace naturals project inc. (ontario), which was the first non-incumbent medical cannabis license granted by health canada, and original bc ltd. (british columbia), which is based in the okanagan valley. the company has multiple international production and distribution platforms: cronos israel and cronos australia. through an exclusive distribution agreement, cronos also has access to over 12,000 pharmacies in germany as the company focuses on building an international iconic brand portfolio and developing disruptive intellectual property.
Cronos Inc executives and other stock owners filed with the SEC include: